Zosano shares soar as its pivotal migraine drug patch study comes through
Zosano Pharmaceuticals $ZSAN went through a very bad year after raising $50 million in an IPO floated at the beginning of 2015. Its two big …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
